Related Experiment Video
Updated: May 17, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Associations of polycyclic aromatic hydrocarbons exposure with perinatal anxiety symptoms
Hualong Zhen1, Yunfei Jia1, Beibei Zhu1,2,3
1School of Public Health, Anhui Medical University, Hefei, 230032, China.
Background:
Polycyclic aromatic hydrocarbons (PAHs) have recently garnered attention for their possible neurotoxic effects. This study was meticulously crafted to assess the influence of PAHs exposure on the emergence of perinatal anxiety symptoms.
Methods:
From April 28, 2020, to July 20, 2021, a case-control study recruiting eligible pregnant women was conducted in two primary hospitals in Hefei City, China. Professionals employed the 7-item Generalized Anxiety Disorder Scale to assess the participants' anxiety symptoms during pregnancy and postpartum via WeChat. Urinary concentrations of 12 hydroxylated PAH metabolites during pregnancy and postpartum were quantified through gas chromatography-tandem triple quadrupole mass spectrometry. Logistic regression analysis and mixed exposure modeling (BKMR model) were employed in our study to probe into the associations between PAHs exposure and perinatal anxiety symptoms.
Results:
Our study incorporated 642 participants (279 cases and 363 controls). Multivariable logistic regression models revealed significant dose-response relationships between the levels of individual PAH metabolites in urine and prenatal anxiety symptoms. Compared to pregnant women in the lowest exposure tertile, those in the highest tertiles of urinary concentrations of 2-OHNA, 9-OHFLU, ∑OHFLU, 2-OHDBF, and ∑OH-PAHs had increased risk of experiencing prenatal anxiety (OR = 1.915, 95%CI: 1.271-2.886; OR = 2.084, 95%CI: 1.358-3.199; OR = 2.055, 95%CI: 1.355-3.117; OR = 1.675, 95%CI: 1.119-2.507; OR = 1.870, 95%CI: 1.228-2.847, respectively). BKMR analysis indicated a significant trend of increasing likelihood of prenatal anxiety symptoms with higher levels of the OH-PAHs mixture. Meanwhile, follow-up of 230 pregnant women until 42 days postpartum revealed that increased prenatal urinary concentrations of 2-OHFLU and ∑OHFLU were associated with a higher risk of postpartum anxiety symptoms (OR = 2.101, 95%CI: 1.000-4.414 for the medium vs. low 2-OHFLU exposure; OR = 2.277, 95%CI: 1.080-4.799 for the high vs. low ∑OHFLU exposure, respectively).
Conclusions:
Our study brings to light a potentially strong positive link between PAHs exposure and perinatal anxiety symptoms.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Social Anxiety Disorder
Panic Disorder
Generalized Anxiety Disorder
Theory of Romantic Attachment in Adulthood

